newdrugapprovals.org
MHLW Japan approved Eisai’s Inovelon (rufinamide) as an adjunctive therapy to other antiepileptic drugs in the treatment of Lennox-Gastaut syndrome
Rufinamide mar26, 2013 The agency approved Eisai’s Inovelon (rufinamide) as an adjunctive therapy to other antiepileptic drugs in the treatment of Lennox-Gastaut syndrome Rufinamide is an ant…